Key Insights

Highlights

Success Rate

84% trial completion

Research Maturity

52 completed trials (66% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

12.7%

10 terminated out of 79 trials

Success Rate

83.9%

-2.6% vs benchmark

Late-Stage Pipeline

15%

12 trials in Phase 3/4

Results Transparency

17%

9 of 52 completed with results

Key Signals

9 with results84% success

Data Visualizations

Phase Distribution

65Total
Not Applicable (9)
P 1 (17)
P 2 (27)
P 3 (12)

Trial Status

Completed52
Terminated10
Unknown10
Recruiting3
Withdrawn2
Not Yet Recruiting1

Trial Success Rate

83.9%

Benchmark: 86.5%

Based on 52 completed trials

Clinical Trials (79)

Showing 20 of 20 trials
NCT06276491Phase 1Recruiting

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

NCT07453082RecruitingPrimary

A Prospective Study to Evaluate miRNA371 and Outcomes in Patients With Newly Diagnosed Germ Cell Tumors

NCT05238883Phase 1Active Not Recruiting

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT03426865Completed

Role of Axumin PET Scan in Germ Cell Tumor

NCT06940804Phase 2WithdrawnPrimary

A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm

NCT00104676Phase 3Completed

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

NCT05012397Phase 2Terminated

Milademetan in Advanced/Metastatic Solid Tumors

NCT06133699Not ApplicableUnknownPrimary

Sentinel Lymph Node Biopsy in Stage AI-IIA Germ Cell Tumors

NCT05063760Not ApplicableUnknownPrimary

Exercise in Testicular Germ Cell Cancer Survivors

NCT00788125Phase 1Terminated

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

NCT00003518Phase 2Completed

Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors

NCT00003800Not ApplicableCompletedPrimary

Diagnostic Study of Patients With Stage I Testicular Cancer

NCT00002520Not ApplicableCompleted

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

NCT05670938Recruiting

Follow-up After Surgery for Testicular Cancer

NCT00002566Phase 3Completed

Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors

NCT02677727CompletedPrimary

Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor

NCT00007813Phase 1Completed

Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors

NCT00651716Terminated

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

NCT03980587UnknownPrimary

Exploratory Study of Molecular Characterization in Patients With Metastatic Germ Cell Tumours Refractory/Resistant to Platinum Treatment

NCT03448822Not Yet RecruitingPrimary

Sentinel Lymph Node Procedure in Testicular Germ Cell Tumour

Scroll to load more

Research Network

Activity Timeline